BLACK DIAMOND THERAPEUTICS INC. - COMMON STOCK
4.4850
08-July-24 11:30:29
15 minutes delayed
Stocks
+0.0150
+0.34%
Today's range
4.3800 - 4.6500
ISIN
N/A
Source
NASDAQ
-
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock
29 Jun 2023 19:57:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock
28 Jun 2023 15:23:52 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer
13 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
02 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
09 May 2023 06:30:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days
18 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
09 Mar 2023 06:30:00 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
27 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
05 Jan 2023 07:00:02 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Announces Changes to Board of Directors
19 Dec 2022 07:00:00 By Nasdaq GlobeNewswire
-
12 Dec 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
09 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
08 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
26 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
06 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
09 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
03 Aug 2022 07:00:01 By Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the Jefferies Global Healthcare Conference
06 Jun 2022 07:00:01 By Nasdaq GlobeNewswire